Vidavo (ATH:VIDAVO) Marketable Securities: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATH:VIDAVO Vidavo SA ATH:VIDAVO
85 GF Score
Price €9.50
GF Value €8.56
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vidavo Marketable Securities?

Vidavo ATH:VIDAVO +5.56% 85 Marketable Securities is €0.00 Mil as of Dec. 2025. GuruFocus rates ATH:VIDAVO with a GF Score™ of 85/100 and a GF Value™ of €8.56 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Vidavo's Marketable Securities for the quarter that ended in Dec. 2025 was €0.00 Mil.

Vidavo  (ATH:VIDAVO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Vidavo Marketable Securities Related Terms

Vidavo Marketable Securities Historical Data

* Premium members only.

The historical data trend for Vidavo's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vidavo Marketable Securities Chart

Vidavo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vidavo Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ATH:VIDAVO
85GF Score
Vidavo SA ATH:VIDAVO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vidavo Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.00 Mil mean?
Vidavo (ATH:VIDAVO) has a Marketable Securities of €0.00 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Vidavo and its competitors.
Is Vidavo's Marketable Securities too high?
Vidavo's current Marketable Securities is €0.00 Mil. Overall, Vidavo has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vidavo's Marketable Securities compare to VEEV and BTSG?
Vidavo's Marketable Securities of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Vidavo and its competitors. Vidavo's current Marketable Securities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vidavo stock overvalued right now?
Based on GuruFocus' analysis, Vidavo (ATH:VIDAVO) is currently considered Modestly Overvalued. The stock's GF Value™ is €8.56, compared to a current price of €9.50 — trading 11% above its estimated fair value. The current Marketable Securities is €0.00 Mil. Vidavo's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Vidavo (ATH:VIDAVO), the current Marketable Securities is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vidavo (ATH:VIDAVO) Overvalued in 2026?

Based on GuruFocus' analysis, Vidavo stock appears to be overvalued. The current stock price of €9.50 is trading 11% above its estimated GF Value™ of €8.56. GuruFocus considers Vidavo to be Modestly Overvalued.

Key valuation signals for ATH:VIDAVO:

  • Marketable Securities: €0.00 Mil
  • GF Value™: €8.56 vs. price of €9.50 (11% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the ATH:VIDAVO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vidavo Business Description

Address 10th km Thessalonikis - N. Moudanion, Balkan Center, Building D, Thessaloniki, GRC, 57001
Vidavo SA develops mobile applications that help citizens on-the-move and medical professionals manage health and wellness. The company serves health and social care providers, policymakers, insurance companies, ICT firms seeking differentiation, patients, telecom operators, and other health-related stakeholders. Its solutions include vida24, vidatrack, and vidahome.
85GF Score

Get the complete analysis for ATH:VIDAVO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.50
Price
€8.56
GF Value